Azitra to Implement Reverse Stock Split, Reducing Outstanding Shares by Over 85%.

Azitra will implement a 1-for-6.66 reverse stock split effective August 21, 2025. The stock will continue to trade under the symbol AZTR on a split-adjusted basis. Total outstanding shares will be reduced from 23.48M to ~3.52M. Azitra shares fell 5% post-market on Monday.

Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company specializing in precision dermatology therapies, has announced a reverse stock split of its common stock. The reverse stock split will take place on August 21, 2025, at a ratio of 1 post-split share for every 6.66 pre-split shares. This move aims to reduce the number of outstanding shares from approximately 23.48 million to around 3.52 million [1][2][3].

The reverse stock split will become effective at 12:01 A.M. Eastern Time on August 21, 2025. Azitra's common stock will continue to be traded on the NYSE American under the symbol "AZTR" and will begin trading on a split-adjusted basis when the market opens on that date. The new CUSIP number for the Company's common stock following the reverse stock split will be 05479L302.

The decision to implement this reverse stock split was approved by the Company's Board of Directors on August 7, 2025. The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. No fractional shares of common stock will be issued in connection with the reverse split. Stockholders of record who otherwise would be entitled to receive fractional shares will be entitled to receive cash (without interest) in lieu of fractional shares, equal to such fraction multiplied by the average of the closing sales prices of the common stock on the NYSE American during regular trading hours for the five consecutive trading days immediately preceding the effective date of the reverse split [1][2][3].

Following the reverse stock split, Azitra will have approximately 3,524,978 shares outstanding. Proportional adjustments will be made to the number of shares of the Company's common stock issuable upon exercise or conversion of the Company's equity awards and warrants, as well as the applicable exercise price.

Azitra's shares fell 5% post-market on Monday following the announcement of the reverse stock split. Investors are advised to direct any questions concerning the reverse stock split to their broker or to the Company's transfer agent, VStock Transfer Company, at action@vstocktransfer.com.

Additional information about the reverse stock split can be found in the Company's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on January 14, 2025, which is available free of charge at the SEC's website, www.sec.gov, and on the Company's website at https://azitrainc.com/.

References:
[1] https://www.prnewswire.com/news-releases/azitra-inc-announces-reverse-stock-split-302526802.html
[2] https://seekingalpha.com/news/4483486-azitra-to-implement-1-for-666-reverse-stock-split
[3] https://www.marketscreener.com/news/azitra-inc-announces-reverse-stock-split-ce7c5ed3d889f023